This product is supplied exclusively for in-vitro laboratory research use. It is not intended for human or animal use, including diagnosis, treatment, mitigation, or prevention of disease.
CJC-1295/Ipamorelin 10mg
$95Purity: 99.94%
Independently Tested
Freedom Diagnostics — USA Lab
🧪 Lab Tested: February 23, 2026
Product ID
CJC-IPAMORELIN
Purity
99.94%
Dosage
10mg
Category
Growth Hormone
| Molecular Formula | C₁₆₅H₂₆₉N₄₇O₄₆ / C₃₈H₄₉N₉O₅ |
| Molecular Weight | 3,647.2 / 711.9 Da |
| Sequence | CJC-1295: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Lys(DAC) / Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
| CAS Number | 863288-34-0 / 170851-70-4 ↗ |
| Purity | 99.94% HPLC |
| Form | Lyophilized Powder |
| Storage | -20°C / -4°F |
Tested by Freedom Diagnostics
HPLC + Mass Spectrometry · USA Lab
About CJC-1295/Ipamorelin
The CJC-1295/Ipamorelin combination is one of the most extensively studied dual-peptide protocols in growth hormone research. This pre-blended formulation contains CJC-1295 (a GHRH analog with Drug Affinity Complex modification for ~6-8 day half-life) and Ipamorelin (a selective GH secretagogue and GHS-R1a agonist) in a single 10mg vial.
The rationale for combining these peptides is based on their complementary mechanisms: CJC-1295 activates GHRH receptors on pituitary somatotrophs, providing sustained GHRH receptor stimulation, while Ipamorelin activates GHS-R1a through a distinct pathway. These two receptor pathways act synergistically, producing greater GH release than either peptide alone. The combination also produces more physiologically relevant pulsatile GH secretion patterns compared to either compound individually.
Research with this combination has examined effects on endogenous GH and IGF-1 levels, body composition parameters, protein synthesis rates, and lipolytic activity in preclinical models. Pure Pharm Peptides' CJC-1295/Ipamorelin blend is verified at 99.94% purity.
Research Applications:
- Synergistic GH secretion through dual receptor pathway studies
- Sustained + pulsatile GH release pattern investigations
- IGF-1 production and downstream anabolic effect research
- Body composition and protein synthesis studies in animal models
- Lipolysis and fat metabolism research
- Comparison of mono- vs. dual-peptide GH secretagogue protocols
Key Specifications:
- Purity: 99.94% verified by Freedom Diagnostics testing
- Dosage: 10mg per vial
- Category: Growth Hormone
- Storage: -20°C or colder (lyophilized)
- Stability: Up to 2 years when stored properly
Research Highlights:
- 99.94% purity verified by Freedom Diagnostics HPLC analysis
- Pre-blended convenience — eliminates need for separate reconstitution
- Synergistic GH release through complementary GHRH + GHS-R1a mechanisms
- CJC-1295 DAC provides sustained receptor stimulation; Ipamorelin adds pulsatile peaks
- Most studied dual-peptide GH protocol in research literature
CJC-1295/Ipamorelin 10mg
This powerful combination blend pairs CJC-1295's long-lasting growth hormone release with Ipamorelin's targeted GH pulse stimulation. Together, they create a synergistic effect for enhanced muscle growth, fat loss, improved sleep quality, and accelerated recovery without the side effects of traditional GH therapy.
Frequently Asked Questions — CJC-1295/Ipamorelin
Customer Reviews
Share & Earn Rewards
Earn $10 when someone buys through your link!
We Accept
Zelle
CryptoMore Options via EmailVenmo, PayPal, Cash App & more available — select "More Payment Options" at checkout.
Share:
Frequently Researched Together
Stay Updated on Research Peptides
Get exclusive updates on new products, COA releases, and research insights delivered to your inbox.
The verified choice for researchers who demand proof, not just claims. Tested by Freedom Diagnostics.
For research purposes only.
Company
Contact
Freedom Diagnostics
Accredited USA Laboratory
WE ACCEPT
© 2026 Pure Pharm Peptides. All rights reserved.
CJC-1295/Ipamorelin
$95